Manipal Health Clears ₹5,310 Cr Debt Using IPO Proceeds
By Business Desk
Manipal Health Enterprises redeems ₹5,310 crore in NCDs using IPO funds and reports strong Q1 FY2027 financial growth, boosting market confidence.
Manipal Health Enterprises Ltd has fully redeemed its outstanding listed non-convertible debentures worth ₹5,310 crore using funds raised from its recent initial public offering. This major debt reduction directly fulfills a key commitment outlined in the company prospectus to clean up the balance sheet.
Key Financial Highlights and Performance Metrics
The strategic debt clearance comes on the heels of robust financial results reported for the first quarter of the 2027 fiscal year. The source details the following performance figures:
- Revenue reached ₹3,091 crore, marking a 38.1% increase year-on-year.
- EBITDA grew by 26.4% to ₹749 crore.
- Adjusted PAT rose by 30.9% to ₹332 crore.
The redemption covers the principal amount along with associated interest and prepayment costs. This decisive action is expected to significantly lower the company interest burden and improve overall financial health.
Strategic Implications for Future Growth
Market analysts anticipate that reduced interest expenses will positively impact future profit margins as the corporate strategy shifts. With a cleaner balance sheet, the organization is positioning itself to focus heavily on capacity expansion and technological investments.